Cargando…

The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease

Emerging evidences demonstrate the involvement of gut microbiota in the progression of chronic kidney disease (CKD) and CKD-associated complications including cardiovascular disease (CVD) and intestinal dysfunction. In this review, we discuss the interactions between the gut, kidney and heart in CKD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yinghui, Xin, Wang, Xiong, Jiachuan, Yao, Mengying, Zhang, Bo, Zhao, Jinghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971625/ https://www.ncbi.nlm.nih.gov/pubmed/35370631 http://dx.doi.org/10.3389/fphar.2022.837500

Ejemplares similares

Characteristics of Serum Metabolites and Gut Microbiota in Diabetic Kidney Disease
por: Zhang, Bo, et al.
Publicado: (2022)

The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease
por: Zhang, Qing, et al.
Publicado: (2021)

Oroxylin A ameliorates AKI-to-CKD transition through maintaining PPARα-BNIP3 signaling-mediated mitochondrial homeostasis
por: Yao, Mengying, et al.
Publicado: (2022)

A Nomogram for Identifying Subclinical Atherosclerosis in Chronic Kidney Disease
por: Xiong, Jiachuan, et al.
Publicado: (2021)

Understanding the Gut-Kidney Axis in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: An Analysis of Gut Microbiota Composition
por: Yu, Meilian, et al.
Publicado: (2022)

T-Lymphocyte Subsets Alteration, Infection and Renal Outcome in Advanced Chronic Kidney Disease
por: Xiong, Jiachuan, et al.
Publicado: (2021)

Editorial: The gut-kidney axis: A potential drug target for treating kidney diseases
por: Chen, Jianping, et al.
Publicado: (2022)

Enteroendocrine cells and gut hormones as potential targets in the crossroad of the gut-kidney axis communication
por: Nery Neto, José Arimatéa de Oliveira, et al.
Publicado: (2023)

The potential mechanism of gut microbiota-microbial metabolites-mitochondrial axis in progression of diabetic kidney disease
por: Ma, Leilei, et al.
Publicado: (2023)

Activated Platelets, the Booster of Chronic Kidney Disease and Cardiovascular Complications
por: Gong, Shuiqin, et al.
Publicado: (2022)

Natural products from plants and microorganisms: Novel therapeutics for chronic kidney disease via gut microbiota regulation
por: Zheng, Lin, et al.
Publicado: (2023)

The Role of Gut Microbiota—Gut—Brain Axis in Perioperative Neurocognitive Dysfunction
por: Lu, Jian, et al.
Publicado: (2022)

The modulation of gut microbiota by herbal medicine to alleviate diabetic kidney disease – A review
por: Du, Jinxin, et al.
Publicado: (2022)

Gut microbiota-derived metabolites in inflammatory diseases based on targeted metabolomics
por: Xu, Hui, et al.
Publicado: (2022)

Targeting Myocardial Mitochondria-STING-Polyamine Axis Prevents Cardiac Hypertrophy in Chronic Kidney Disease
por: Han, Wenhao, et al.
Publicado: (2022)

Gut Microbiota Composition and Its Metabolites in Different Stages of Chronic Kidney Disease
por: Chen, Tso-Hsiao, et al.
Publicado: (2021)

The alleviating effect of Scutellaria amoena extract on the regulation of gut microbiota and its metabolites in NASH rats by inhibiting the NLRP3/ASC/caspase-1 axis
por: Lin, Yu-Ping, et al.
Publicado: (2023)

Bletilla striata Oligosaccharides Improve Ulcerative Colitis by Regulating Gut Microbiota and Intestinal Metabolites in Dextran Sulfate Sodium-Induced Mice
por: Zhu, Tianxiang, et al.
Publicado: (2022)

Gut Microbiota-Regulated Pharmacokinetics of Berberine and Active Metabolites in Beagle Dogs After Oral Administration
por: Feng, Ru, et al.
Publicado: (2018)

Preventive effects of the Rehmannia glutinosa Libosch and Cornus officinalis Sieb herb couple on chronic kidney disease rats via modulating the intestinal microbiota and enhancing the intestinal barrier
por: Wang, Ling, et al.
Publicado: (2022)

Effective Regulation of Gut Microbiota With Probiotics and Prebiotics May Prevent or Alleviate COVID-19 Through the Gut-Lung Axis
por: Xu, Lei, et al.
Publicado: (2022)

Chronic kidney disease and gut microbiota
por: Amini Khiabani, Siamak, et al.
Publicado: (2023)

Activation of EP4 alleviates AKI-to-CKD transition through inducing CPT2-mediated lipophagy in renal macrophages
por: Guan, Xu, et al.
Publicado: (2022)

Potential Role of the Renal Arterial Resistance Index in the Differential Diagnosis of Diabetic Kidney Disease
por: Li, Haiyang, et al.
Publicado: (2022)

Ginsenoside Rc ameliorated atherosclerosis via regulating gut microbiota and fecal metabolites
por: Xie, Bin, et al.
Publicado: (2022)

Rhubarb Enema Decreases Circulating Trimethylamine N-Oxide Level and Improves Renal Fibrosis Accompanied With Gut Microbiota Change in Chronic Kidney Disease Rats
por: Ji, Chunlan, et al.
Publicado: (2021)

The gut-lung axis: Gut microbiota changes associated with pulmonary fibrosis in mouse models induced by bleomycin
por: Quan, Yunyun, et al.
Publicado: (2022)

Gut–Kidney Axis Investigations in Animal Models of Chronic Kidney Disease
por: Bartochowski, Piotr, et al.
Publicado: (2022)

Intestinal homeostasis in the gut-lung-kidney axis: a prospective therapeutic target in immune-related chronic kidney diseases
por: Liu, Xinyin, et al.
Publicado: (2023)

The effectiveness of multidisciplinary care models for patients with chronic kidney disease: a systematic review and meta-analysis
por: Shi, Yu, et al.
Publicado: (2017)

Modulation of Gut Microbiota and Metabolites by Berberine in Treating Mice With Disturbances in Glucose and Lipid Metabolism
por: Fang, Xinyi, et al.
Publicado: (2022)

Homeostasis in the Gut Microbiota in Chronic Kidney Disease
por: Bhargava, Shruti, et al.
Publicado: (2022)

Antiplatelet therapy for the prevention of atherosclerosis in chronic kidney disease (ALTAS-CKD) patients: study protocol for a randomized clinical trial
por: Xiong, Jiachuan, et al.
Publicado: (2021)

The Ameliorative Effects of Isorhynchophylline on Morphine Dependence Are Mediated Through the Microbiota-Gut-Brain Axis
por: Chen, Zhu, et al.
Publicado: (2021)

The Endocannabinoids-Microbiota Partnership in Gut-Brain Axis Homeostasis: Implications for Autism Spectrum Disorders
por: Coccurello, Roberto, et al.
Publicado: (2022)

Effect of polymorphisms in drug metabolism and transportation on plasma concentration of atorvastatin and its metabolites in patients with chronic kidney disease
por: Jiang, Zebin, et al.
Publicado: (2023)

Gut Microbiota-Based Pharmacokinetics and the Antidepressant Mechanism of Paeoniflorin
por: Yu, Jin-Bo, et al.
Publicado: (2019)

Plasma Metabolites and Gut Microbiota Are Associated With T cell Imbalance in BALB/c Model of Eosinophilic Asthma
por: Zhou, Yumei, et al.
Publicado: (2022)

Bridging intestinal immunity and gut microbiota by metabolites
por: Wang, Gang, et al.
Publicado: (2019)

Olanzapine-induced lipid disturbances: A potential mechanism through the gut microbiota-brain axis
por: Zhu, Zhenyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_veclk4f9b2acmkgnu0e1fu46ob